ALT elevation was associated with a significantly elevated risk of HCC (adjusted HR 2.75, 95%CI 1.89–3.98) compared to those maintained normal ALT (Supplementary Table 1). The gene discussed is GPT; the disease is hepatocellular carcinoma.